Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Behavioral treatments, including therapy, are often the first recommendation for treating eating disorders
Hypotheses include medication-related blood pressure changes, volume depletion from gastrointestinal effects, rapid glycemic improvement leading to transient vascular dysregulation, and altered autoregulation of optic nerve head perfusion
Things like healthy eating, regular exercise, proper sleep, and managing stress all play a role in results, no matter what product is used
And the evidence base is not comparable
Research Applications & Usage Information IGF-1 LR3 (1 mg) is commonly incorporated into laboratory and preclinical research involving: IGF-1 receptor activation and binding affinity studies Myoblast and muscle cell culture experiments Cellular proliferation and differentiation assays Protein synthesis and anabolic signaling research Intracellular signaling pathway analysis (e.g., PI3K/Akt, MAPK/ERK) Comparative evaluation of native IGF-1 versus long-acting analogs Metabolic regulation and glucose-uptake research models Tissue growth and regenerative pathway investigations All applications are investigational and limited to in vitro or preclinical research settings
US$ 21.15
US$ 20.37
US$ 28.36
US$ 29.30
